104 - Cefazolin vs. Nafcillin for MSSA Infections: Pro-Con Debate

10/4/2019

8:00 AM - 9:00 AM

Room: Walter E. Washington Convention Center, 151 AB

MOC Credit: Maximum of 1.0 hours of MOC Credit
CME Credit: Maximum of 1.0 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-359-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the clinical approach using nafcillin vs cefazolin for deep-seated MSSA infections
review the available data favoring one antibiotic over to treat invasive MSSA infections
analyze data related to the cefazolin inoculum effect in an area of high prevalence

Presentations:

8:00 AM - 9:00 AM
910 - Cefazolin versus Nafcillin for MSSA Infections: Pro-Con Discussion
Sarah B. Doernberg, MD, MAS – University of California, San Francisco
8:00 AM - 9:00 AM
909 - Cefazolin versus Nafcillin for MSSA Infections: Pro-Con Discussion
Esteban C. Nannini, MD – Facultad Ciencias Médicas - Universidad Nacional de Rosario

Speaker(s)

Sarah Doernberg, MD, MAS

Associate Professor
University of California, San Francisco
San Francisco, California

Disclosure: Genentech: Consultant
EN

Esteban Nannini, MD

Associate Professor
Facultad Ciencias Médicas - Universidad Nacional de Rosario
Rosario, Argentina

Disclosure: Basilea: Research Grant
Janssen Pharm: Research Grant
Merck, Sharpe, and Dohme: Speaker's Bureau
Pfizer, Inc: Consultant, Research Grant, Speaker's Bureau